Viyash Scientific Ltd.

NSE: VIYASH | BSE: 512529 | ISIN: INE807F01027 | Industry: Pharmaceuticals
| Mid-range Performer
204.9600 -1.91 (-0.92%)
NSE Apr 09, 2026 15:51 PM
Volume: 1.4M
 

204.96
-0.92%
ICICI Securities Limited
We met the management of Sequent Scientific (Sequent) to gain an insight into the company's animal health business. Sequent is a vertically integrated, global animal health company with seven manufacturing facilities in India, Spain, Germany, Brazil and Turkey. Formulations contributed ~75% of total revenues in FY18 with the rest from API segment. In formulations, the company has a strong presence in Europe, Latin America, Turkey, India, Africa and Southeast Asia markets. Recently, it forayed into France and Ukraine. In API segment, top 10 global animal...
Number of FII/FPI investors decreased from 72 to 52 in Dec 2025 qtr
More from Viyash Scientific Ltd.
Recommended